Zefia Horhey

Doctor of Medicine,  Charité - Universitätsmedizin Berlin 

Location: India

Consulting Services

Biostatistics Hospital-Pharmacy-Insurance Research Consulting Legal Support Career Advice and Mentoring

Areas Of Interest

Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate State of Qatar Dystonia Syndromes, Blepharospasm-Oromandibular Lipoatrophic Diabetes, Congenital Cold Shock Peptides Spindles, Neuromuscular Retroversions, Uterine Proto-Oncogene Protein c-fli-1 Astronomical Phenomena Physiological Phenomena, Nutrition Bax delta Protein Spectacled Porpoises True Crabs Cation Channel, Cng Manipulation, Psychological Protective Agents, Radiation Banisterine Social Competence Controlled Clinical Trial Cycle, Citric Acid Enlargement, Physiological Heart Physiological Phenomena Ergometrin Overactivity Syndrome, Hypothalamic Antigen, Macrophage-1 Cuneus Cortex

Professional Narrative

Dr. Zefia Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Amgen 2008
Director Medicine, Amgen 2012

Education

Doctor of medicine, Perelman School of Medicine 1999
Bachelor of science in nursing, Harvard Medical School 2017

Referees

Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02